Kitazato

Kitazato Capital Intensity

The Capital Intensity Ratio of Kitazato (368A.T) as of Nov 17, 2026 is 191.69 %. In the previous year, Capital Intensity Ratio was 177.15 % — a change of 8.21% (higher).

Capital Intensity

191.69 %

YoY

8.21%

Last updated:

Capital Intensity Ratio of Kitazato is 2025 191.69 % . Capital Intensity Ratio of Kitazato was 2024 177.15 % . It decreases by 8.21% higher compared to the previous year.

The Kitazato Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2023
165.82 JPY
Jan 1, 2024
177.15 JPY
Jan 1, 2025
191.69 JPY
The Kitazato Capital Intensity history
YEARCapital IntensityYoY
191.69 %+8.21%
177.15 %+6.83%
165.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Capital Intensity Ratio of Kitazato is 191.69 % in 2025.

Capital Intensity Ratio of Kitazato changed from 177.15 % to 191.69 %, representing a 8.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Kitazato since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Kitazato with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Kitazato

All Key Metrics — Kitazato